Y. Benhamou

5.3k citations

189 papers · 3.7k · 2 hit papers · h-index 33

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Nephrology top 1%
- Renal Diseases and Glomerulopathies

Papers in

Hematology 40
- Platelet Disorders and Treatments 20
Immunology 51
- Complement system in diseases 44

Co-authors: Hervé Levesque (56 shared papers)Paul Coppo (27 shared papers)Agnès Veyradier (15 shared papers)sebastien MIRANDA (19 shared papers)Maelle le Besnerais (15 shared papers)Pascale Poullin (7 shared papers)Lionel Galicier (9 shared papers)François Provôt (7 shared papers)
Journals: Blood (12 papers)Thrombosis Research (5 papers)Archives of cardiovascular diseases (4 papers)Lara D. Veeken (4 papers)Journal of Hepatology (4 papers)
Partner nations: France Italy United States

In The Last Decade

Y. Benhamou

175 papers receiving 3.6k citations

Y. Benhamou's Hit Papers

align trajectories log scale

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial 2025 · 38 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2025 The Lancet
2021 The Lancet Rheumatology

Peers

Countries citing papers authored by Y. Benhamou

Since Specialization

Citations

This map shows the geographic impact of Y. Benhamou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Benhamou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Benhamou more than expected).

Fields of papers citing papers by Y. Benhamou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Benhamou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Benhamou. The network helps show where Y. Benhamou may publish in the future.

Co-authors

The 25 scholars most cited alongside Y. Benhamou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Y. Benhamou Line = papers co-authored together Y. Benhamou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy The Lancet Haematology ·Éric Mariotte, Élie Azoulay, Lionel Galicier, Eric Rondeau, Fouzia Zouiti, Pierre Boisseau, Pascale Poullin, Emmanuel de Maistre	2016	242
2	COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study The Lancet Rheumatology ·Jérôme Avouac, Élodie Drumez, Eric HACHULLA, Raphaele Seror, Sophie Georgin‐Lavialle, Soumaya El Mahou, Édouard Pertuiset, Thao Pham Hit paper breakdown →	2021	209
3	Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis Circulation ·Cloé Comarmond, Lucie Biard, M. Lambert, Arsène MEKINIAN, Yasmina Ferfar, Jean‐Emmanuel Kahn, Y. Benhamou, L. Chiche	2017	174
4	Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura Blood ·Julie Gay, Lionel Galicier, François Provôt, Claire Presne, Pascale Poullin, G. Bonmarchand, Alain Wynckel, Y. Benhamou	2014	156
5	A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP Blood ·Paul Coppo, Michaël Bubenheim, Élie Azoulay, Lionel Galicier, Sandrine Malot, Naïke Bigé, Pascale Poullin, François Provôt	2020	146
6	Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) La Revue de Médecine Interne ·Boris Bienvenu, Kim Heang Ly, M. Lambert, C. Agard, Marie Hélène André, Y. Benhamou, Bernard Bonnotte, Hubert de Boysson	2016	143
7	Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura Blood ·Matthieu Jestin, Y. Benhamou, An‐Sofie Schelpe, Elien Roose, François Provôt, Lionel Galicier, Claire Presne, Pascale Poullin	2018	131
8	Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center Journal of Thrombosis and Haemostasis ·Y. Benhamou, Pierre‐Yves Boëlle, B. Baudin, Stéphane Éderhy, Jeremie M. Gras, Lionel Galicier, Élie Azoulay, François Provôt	2014	114
9	Facebook activity of residents and fellows and its impact on the doctor–patient relationship Journal of Medical Ethics ·Ghassan Moubarak, Aurélie Guiot, Y. Benhamou, Alexandra Benhamou, Sarah Hariri	2010	113
10	Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial European Heart Journal ·Pierre‐Marie Roy, Andréa Penaloza, Olivier William Hugli, Frederikus Albertus Klok, Armelle Arnoux, Antoine Élias, Françis Couturaud, Luc‐Marie Joly	2021	108
11	Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients Journal of Autoimmunity ·Adrien Mirouse, Lucie Biard, Cloé Comarmond, M. Lambert, Arsène MEKINIAN, Yasmina Ferfar, Jean‐Emmanuel Kahn, Y. Benhamou	2018	69
12	Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura Blood ·Elien Roose, An‐Sofie Schelpe, Edwige Tellier, György Sinkovits, Bérangère S. Joly, Charlotte Dekimpe, Gilles Kaplanski, Maelle le Besnerais	2020	66
13	Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction PLoS ONE ·sebastien MIRANDA, Paul Billoir, Louise Damian, Pierre‐Alain Thiébaut, Damien Schapman, Maelle le Besnerais, Fabienne Jouen, Ludovic Galas	2019	65
14	Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte Revue des Maladies Respiratoires ·Olivier Sanchez, Y. Benhamou, Laurent Bertoletti, Jacques Constant, Françis Couturaud, Aurélien Delluc, Antoine Élias, Alec M. Fischer	2019	59
15	Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency The Lancet ·Steven Grangé, Soumeya Bekri, Elise Artaud-Macari, Arnaud François, Christophe Girault, Anne-Laure Poitou, Y. Benhamou, Christine Vianey‐Saban	2015	57
16	Role of Toll‐like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome Arthritis & Rheumatology ·Y. Benhamou, Jérémy Bellien, G. Armengol, Ebba Bråkenhielm, Sahil Adriouch, Michèle Iacob, Isabelle Rémy‐Jouet, Véronique Le Cam‐Duchez	2014	50
17	Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry Annals of the Rheumatic Diseases ·Benjamin de Valence de Minardiere, Marion Delaune, Yann Nguyen, Vincent Jachiet, Maël Heiblig, Alexis Jean, Stanislas Riescher Tuczkiewicz, Pierrick Henneton	2023	47
18	Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival Blood ·Renaud Prével, Claire Roubaud Baudron, Samuel Gourlain, Matthieu Jamme, Karine Pérès, Y. Benhamou, Lionel Galicier, Élie Azoulay	2019	44
19	Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study American Journal of Hematology ·Y. Benhamou, Gilles Paintaud, Élie Azoulay, Pascale Poullin, Lionel Galicier, Céline Desvignes, Jean-Luc Baudel, Julie Peltier	2016	43
20	Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease Joint Bone Spine ·Christopher Banse, Olivier Vittecoq, Y. Benhamou, Maud Gauthier-Prieur, Thierry Lequerré, Hervé Levesque	2013	42

About Y. Benhamou

Y. Benhamou is a scholar working on Hematology, Immunology, Internal Medicine, Genetics and Nephrology, having authored 189 papers that have together received 3.7k indexed citations. Recurring topics across this work include Complement system in diseases (44 papers), Venous Thromboembolism Diagnosis and Management (24 papers), Vasculitis and related conditions (20 papers), Platelet Disorders and Treatments (20 papers), Renal Diseases and Glomerulopathies (18 papers), Systemic Lupus Erythematosus Research (16 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). The work is most often cited by research in Internal Medicine (334 citations), Nephrology (623 citations), Hematology (772 citations), Immunology (1.4k citations) and Genetics (532 citations). Y. Benhamou has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Hervé Levesque, Paul Coppo, Agnès Veyradier, sebastien MIRANDA, Maelle le Besnerais, Pascale Poullin, Lionel Galicier, François Provôt, Ghassan Moubarak and Aurélie Guiot. Their work appears in journals such as Blood, Thrombosis Research, Archives of cardiovascular diseases, Lara D. Veeken and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Y. Benhamou

Impact in

Papers in i

In The Last Decade

Y. Benhamou

Y. Benhamou's Hit Papers

Peers

Countries citing papers authored by Y. Benhamou

Fields of papers citing papers by Y. Benhamou

All Works

About Y. Benhamou

Explore authors with similar magnitude of impact

Papers in